FirmaIQ
Org.nr 990 646 066 2013 → 2014 Year-over-year analysis

NYKODE THERAPEUTICS ASA: årsregnskap 2014 vs 2013

Grew 76% on revenue, fresh owner capital

approved 2015-03-09; registry 2015-09-15; journal 2015 831194

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2014 with 2013 for NYKODE THERAPEUTICS ASA. Revenue 4.95m NOK → 8.73m NOK (+76.3%). Equity 9.23m NOK → 30.16m NOK.

On the constructive side: revenue rose; equity strengthened; owners injected capital. Pressures included: cash fell.

Also worth watching: payroll increased. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.

At a glance

Scorecard

Revenue
4.95m NOK 8.73m NOK
+76.3%
Operating result
-3.47m NOK n/m
—
Equity
9.23m NOK 30.16m NOK
+226.6%
Cash
9.49m NOK 9.33m NOK
-1.6%
Total assets
11.61m NOK 34.04m NOK
+193.2%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 4.95m NOK to 8.73m NOK (+76.3% YoY). Calculated

  • ↑

    Equity strengthened

    Book equity 9.23m NOK → 30.16m NOK (equity ratio 79.5% → 88.6%). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 23.19m NOK → 55.81m NOK (+32.62m NOK). Reported fact

What deteriorated

  • ↓

    Cash fell

    Bank deposits 9.49m NOK → 9.33m NOK (-1.6% YoY). Calculated

Things to notice

  • ·

    Payroll increased

    Salary cost 2.30m NOK → 5.96m NOK (47% → 68% of revenue). Calculated